ISRCTN03911524已完成不适用
PRE-emptive therapy of acute Graft Versus Host Disease according to specific proteomic patterns after allogeneic haematopoietic stem cell transplantatio
Hannover Medical School (Germany)0 个研究点目标入组 580 人开始时间: 2007年12月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 580
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. All patients greater than 18 years after allogeneic haematopoietic stem cell transplantation (allo-HSCT)
- •2. Informed consent
排除标准
- •1. Severe infections at the time of aGvHD-pattern positivity
- •2. No informed consent
研究者
相似试验
进行中（未招募）
不适用
Early therapy of acute bone marrow rejection according to specific proteins detected in urine after bone marrow transplantation.Pre-emptive therapy of acute graft versus host disease with prednisolone according to specific proteomic patterns after allogeneic hematopoietic stem cell transplantation.MedDRA version: 16.1Level: LLTClassification code 10018652Term: Graft versus host reactionSystem Organ Class: 100000004870EUCTR2008-005862-30-DEMedizinische Hochschule Hannover
进行中（未招募）
1 期
Prevention of graft-against-host disease in patients treated with allogeneic stem cell transplantation: Possible role of extracorporeal photophoresisGraft-versus-host disease (GVHD), both acute and chronic untill one year after allogeneic stam cell transplatationEUCTR2017-000614-39-NOOSLO UNIVERSITY HOSPITAL HF156
进行中（未招募）
3 期
GRAPPA2023-510441-24-00DKMS Group gGmbH640
招募中
2 期
Single agent GVHD prophylaxis with PTCY for SCT: a phase II studyeukemia/lymphomaHematologic malignancyJPRN-jRCTs031180399Sakaguchi Hirotoshi30
招募中
不适用
Single agent graft-versus-host disease prophylaxis with post-transplant cyclophosphamide for stem cell transplantation: a phase II study (SAP-P2)Acute leukemiaJPRN-UMIN000021375ational Center for Child Health and Development30